Sanara MedTech (SMTI) Net Income towards Common Stockholders (2010 - 2026)
Sanara MedTech (SMTI) posted Net Income towards Common Stockholders of $60916.0 for Q1 2026, up 102.42% on a QoQ basis from -$2.5 million in Q4 2025, and up 102.1% year-over-year from $30142.2 in Q1 2025.
Sanara MedTech (SMTI) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Sanara MedTech's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at $60916.0 for Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 102.1% year-over-year to $60916.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.4 million (down 122.39% YoY) and the FY2025 annual result came in at -$37.2 million, down 366.18% from the prior year.
- Net Income towards Common Stockholders was $60916.0 for Q1 2026 at Sanara MedTech, up from -$2.5 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $60916.0 in Q1 2026 and bottomed at -$31.2 million in Q3 2025.
- A 5-year average of -$4.3 million and a median of -$2.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders slumped 2907.2% — and 2026, when it surged 102.1%.
- Sanara MedTech's Net Income towards Common Stockholders stood at -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then slumped by 2907.2% to -$7.9 million in 2024, then soared by 68.09% to -$2.5 million in 2025, then jumped by 102.42% to $60916.0 in 2026.
- Business Quant data shows SMTI's Net Income towards Common Stockholders at $60916.0 in Q1 2026, -$2.5 million in Q4 2025, and -$31.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Sanara MedTech | 228.72 Mn | 215.13 Mn | 25.87 Mn | 60,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,916.00 |
| Dec 31, 2025 | -2.52 Mn |
| Sep 30, 2025 | -31.25 Mn |
| Jun 30, 2025 | -3.66 Mn |
| Mar 31, 2025 | -2.91 Mn |
| Dec 31, 2024 | -7.89 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Jun 30, 2024 | -3.30 Mn |
| Mar 31, 2024 | -1.80 Mn |
| Dec 31, 2023 | -262,444.00 |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | -1.87 Mn |
| Mar 31, 2023 | -1.30 Mn |
| Dec 31, 2022 | -4.16 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | -3.25 Mn |
| Mar 31, 2022 | -3.13 Mn |
| Dec 31, 2021 | -3.55 Mn |
| Sep 30, 2021 | -2.02 Mn |
| Jun 30, 2021 | -1.17 Mn |